| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | 2.63e-05 | 739 | 11 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.73e-04 | 560 | 11 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.80e-04 | 566 | 11 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 2.70e-04 | 45 | 11 | 2 | GO:0043175 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.22e-04 | 303 | 11 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 5.63e-04 | 65 | 11 | 2 | GO:0070063 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 5.65e-04 | 1412 | 11 | 5 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 6.58e-04 | 1459 | 11 | 5 | GO:0000977 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.27e-03 | 98 | 11 | 2 | GO:0031491 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.32e-03 | 417 | 11 | 3 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.09e-03 | 562 | 11 | 3 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.41e-03 | 582 | 11 | 3 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 4.54e-03 | 187 | 11 | 2 | GO:0016922 | |
| GeneOntologyMolecularFunction | transcription factor binding | 7.02e-03 | 753 | 11 | 3 | GO:0008134 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.44e-06 | 171 | 11 | 4 | GO:0048593 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 2.90e-06 | 204 | 11 | 4 | GO:0048592 | |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 3.25e-06 | 57 | 11 | 3 | GO:0030520 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 1.34e-05 | 91 | 11 | 3 | GO:0048663 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 1.70e-05 | 12 | 11 | 2 | GO:0033148 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 1.89e-05 | 1269 | 11 | 6 | GO:0009887 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.26e-05 | 343 | 11 | 4 | GO:0090596 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.28e-05 | 741 | 11 | 5 | GO:0006338 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 3.70e-05 | 389 | 11 | 4 | GO:0022409 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 3.94e-05 | 18 | 11 | 2 | GO:0033145 | |
| GeneOntologyBiologicalProcess | epithelium development | 4.37e-05 | 1469 | 11 | 6 | GO:0060429 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 4.45e-05 | 136 | 11 | 3 | GO:0030518 | |
| GeneOntologyBiologicalProcess | radial glial cell differentiation | 4.89e-05 | 20 | 11 | 2 | GO:0060019 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 5.04e-05 | 421 | 11 | 4 | GO:0060562 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 5.28e-05 | 426 | 11 | 4 | GO:0043010 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 5.28e-05 | 144 | 11 | 3 | GO:0045582 | |
| GeneOntologyBiologicalProcess | chromatin organization | 5.68e-05 | 896 | 11 | 5 | GO:0006325 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 6.57e-05 | 155 | 11 | 3 | GO:0043401 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 7.49e-05 | 162 | 11 | 3 | GO:0045621 | |
| GeneOntologyBiologicalProcess | dorsal/ventral neural tube patterning | 7.71e-05 | 25 | 11 | 2 | GO:0021904 | |
| GeneOntologyBiologicalProcess | eye development | 8.39e-05 | 480 | 11 | 4 | GO:0001654 | |
| GeneOntologyBiologicalProcess | visual system development | 8.60e-05 | 483 | 11 | 4 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 9.17e-05 | 491 | 11 | 4 | GO:0048880 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 9.54e-05 | 999 | 11 | 5 | GO:0071824 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 9.91e-05 | 178 | 11 | 3 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 1.04e-04 | 29 | 11 | 2 | GO:2000819 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.36e-04 | 198 | 11 | 3 | GO:0048754 | |
| GeneOntologyBiologicalProcess | neural tube development | 1.44e-04 | 202 | 11 | 3 | GO:0021915 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.44e-04 | 202 | 11 | 3 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 1.61e-04 | 36 | 11 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 1.73e-04 | 579 | 11 | 4 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.74e-04 | 580 | 11 | 4 | GO:0022407 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.79e-04 | 1141 | 11 | 5 | GO:0045597 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 1.91e-04 | 594 | 11 | 4 | GO:0007346 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 2.01e-04 | 226 | 11 | 3 | GO:0045580 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 2.20e-04 | 42 | 11 | 2 | GO:0070316 | |
| GeneOntologyBiologicalProcess | neuron fate specification | 2.20e-04 | 42 | 11 | 2 | GO:0048665 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.24e-04 | 619 | 11 | 4 | GO:0002009 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 2.28e-04 | 236 | 11 | 3 | GO:0061138 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 2.37e-04 | 239 | 11 | 3 | GO:0071383 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 2.42e-04 | 44 | 11 | 2 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 2.46e-04 | 242 | 11 | 3 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 2.46e-04 | 242 | 11 | 3 | GO:1903708 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 2.52e-04 | 244 | 11 | 3 | GO:0009755 | |
| GeneOntologyBiologicalProcess | neural tube patterning | 2.53e-04 | 45 | 11 | 2 | GO:0021532 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 2.86e-04 | 255 | 11 | 3 | GO:0045664 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 2.96e-04 | 258 | 11 | 3 | GO:0001763 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 3.24e-04 | 266 | 11 | 3 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 3.25e-04 | 51 | 11 | 2 | GO:1902459 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 3.64e-04 | 54 | 11 | 2 | GO:0045663 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 4.14e-04 | 727 | 11 | 4 | GO:0032870 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 4.17e-04 | 290 | 11 | 3 | GO:0050870 | |
| GeneOntologyBiologicalProcess | sensory organ development | 4.21e-04 | 730 | 11 | 4 | GO:0007423 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 4.52e-04 | 1390 | 11 | 5 | GO:0045944 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 4.66e-04 | 750 | 11 | 4 | GO:0048729 | |
| GeneOntologyBiologicalProcess | embryo development | 5.28e-04 | 1437 | 11 | 5 | GO:0009790 | |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 5.28e-04 | 65 | 11 | 2 | GO:0060443 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 5.28e-04 | 65 | 11 | 2 | GO:0045815 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 5.41e-04 | 317 | 11 | 3 | GO:1903039 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 5.77e-04 | 324 | 11 | 3 | GO:0006302 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 5.78e-04 | 68 | 11 | 2 | GO:0141137 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 6.09e-04 | 330 | 11 | 3 | GO:0040029 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 6.53e-04 | 338 | 11 | 3 | GO:0045165 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 7.60e-04 | 78 | 11 | 2 | GO:2000036 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 8.18e-04 | 870 | 11 | 4 | GO:0030855 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 8.36e-04 | 875 | 11 | 4 | GO:0045596 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 9.24e-04 | 381 | 11 | 3 | GO:0048545 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 9.31e-04 | 382 | 11 | 3 | GO:0030217 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 9.44e-04 | 87 | 11 | 2 | GO:0033143 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 9.52e-04 | 906 | 11 | 4 | GO:0043009 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 9.52e-04 | 385 | 11 | 3 | GO:0051251 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 9.65e-04 | 88 | 11 | 2 | GO:0006289 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 1.04e-03 | 927 | 11 | 4 | GO:0030155 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 1.05e-03 | 929 | 11 | 4 | GO:0009792 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 1.05e-03 | 92 | 11 | 2 | GO:0045661 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 1.08e-03 | 402 | 11 | 3 | GO:1901990 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron differentiation | 1.10e-03 | 94 | 11 | 2 | GO:0045665 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 1.12e-03 | 95 | 11 | 2 | GO:0030071 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 1.12e-03 | 95 | 11 | 2 | GO:2000781 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.19e-03 | 416 | 11 | 3 | GO:0030522 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.20e-03 | 98 | 11 | 2 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 1.24e-03 | 100 | 11 | 2 | GO:0007091 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.25e-03 | 423 | 11 | 3 | GO:0002696 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.30e-03 | 429 | 11 | 3 | GO:1902105 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.32e-03 | 103 | 11 | 2 | GO:0044784 | |
| GeneOntologyBiologicalProcess | regulation of smoothened signaling pathway | 1.37e-03 | 105 | 11 | 2 | GO:0008589 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 1.42e-03 | 107 | 11 | 2 | GO:0009953 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 1.45e-03 | 1014 | 11 | 4 | GO:0000278 | |
| GeneOntologyCellularComponent | bBAF complex | 1.13e-05 | 10 | 11 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 2.28e-05 | 14 | 11 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 2.28e-05 | 14 | 11 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 3.01e-05 | 16 | 11 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | chromatin | 4.22e-05 | 1480 | 11 | 6 | GO:0000785 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.09e-04 | 30 | 11 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.12e-03 | 96 | 11 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 2.00e-03 | 129 | 11 | 2 | GO:1904949 | |
| GeneOntologyCellularComponent | transcription regulator complex | 3.21e-03 | 596 | 11 | 3 | GO:0005667 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 4.25e-03 | 1377 | 11 | 4 | GO:0140513 | |
| HumanPheno | Hypospadias | 4.01e-05 | 377 | 7 | 5 | HP:0000047 | |
| HumanPheno | Displacement of the urethral meatus | 5.17e-05 | 397 | 7 | 5 | HP:0100627 | |
| HumanPheno | Abnormal male urethral meatus morphology | 5.29e-05 | 399 | 7 | 5 | HP:0032076 | |
| HumanPheno | Hirsutism | 9.95e-05 | 216 | 7 | 4 | HP:0001007 | |
| HumanPheno | Abnormality of the urethra | 1.12e-04 | 465 | 7 | 5 | HP:0000795 | |
| HumanPheno | Aplasia/hypoplasia of the uterus | 1.30e-04 | 81 | 7 | 3 | HP:0008684 | |
| HumanPheno | Hypoplastic fifth fingernail | 1.46e-04 | 14 | 7 | 2 | HP:0008398 | |
| HumanPheno | Prominent eyelashes | 2.18e-04 | 17 | 7 | 2 | HP:0011231 | |
| HumanPheno | Oral aversion | 2.18e-04 | 17 | 7 | 2 | HP:0012523 | |
| HumanPheno | Hypoplastic fifth toenail | 2.74e-04 | 19 | 7 | 2 | HP:0011937 | |
| HumanPheno | Abnormal consumption behavior | 3.54e-04 | 299 | 7 | 4 | HP:0040202 | |
| HumanPheno | Short distal phalanx of finger | 4.06e-04 | 119 | 7 | 3 | HP:0009882 | |
| HumanPheno | Papillary thyroid carcinoma | 4.40e-04 | 24 | 7 | 2 | HP:0002895 | |
| HumanPheno | Aplasia of the uterus | 4.40e-04 | 24 | 7 | 2 | HP:0000151 | |
| HumanPheno | Aplasia/Hypoplasia of the distal phalanges of the hand | 4.59e-04 | 124 | 7 | 3 | HP:0009835 | |
| HumanPheno | Abnormal eating behavior | 5.04e-04 | 128 | 7 | 3 | HP:0100738 | |
| HumanPheno | Wide nasal base | 6.02e-04 | 28 | 7 | 2 | HP:0012810 | |
| HumanPheno | Hepatoblastoma | 6.02e-04 | 28 | 7 | 2 | HP:0002884 | |
| HumanPheno | Dandy-Walker malformation | 6.70e-04 | 141 | 7 | 3 | HP:0001305 | |
| HumanPheno | Abnormal nasal base norphology | 6.91e-04 | 30 | 7 | 2 | HP:0012808 | |
| HumanPheno | Giant somatosensory evoked potentials | 7.57e-04 | 147 | 7 | 3 | HP:0001312 | |
| HumanPheno | Agenesis of corpus callosum | 7.63e-04 | 365 | 7 | 4 | HP:0001274 | |
| HumanPheno | Abnormal penis morphology | 8.66e-04 | 712 | 7 | 5 | HP:0000036 | |
| HumanPheno | Decreased circulating cortisol level | 8.89e-04 | 34 | 7 | 2 | HP:0008163 | |
| HumanPheno | Patent ductus arteriosus | 9.08e-04 | 382 | 7 | 4 | HP:0001643 | |
| HumanPheno | Neoplasm by histology | 9.17e-04 | 383 | 7 | 4 | HP:0011792 | |
| HumanPheno | Abnormality of somatosensory evoked potentials | 9.88e-04 | 161 | 7 | 3 | HP:0007377 | |
| HumanPheno | Dysplastic corpus callosum | 1.03e-03 | 395 | 7 | 4 | HP:0006989 | |
| HumanPheno | Abnormality of the female genitalia | 1.05e-03 | 741 | 7 | 5 | HP:0010460 | |
| HumanPheno | Abnormal fourth ventricle morphology | 1.06e-03 | 165 | 7 | 3 | HP:0010950 | |
| HumanPheno | Dilated fourth ventricle | 1.06e-03 | 165 | 7 | 3 | HP:0002198 | |
| HumanPheno | Cerebellar cyst | 1.08e-03 | 166 | 7 | 3 | HP:0002350 | |
| HumanPheno | Abnormality of skeletal maturation | 1.14e-03 | 405 | 7 | 4 | HP:0000927 | |
| HumanPheno | Thick nasal alae | 1.17e-03 | 39 | 7 | 2 | HP:0009928 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 1.24e-03 | 174 | 7 | 3 | HP:0009832 | |
| HumanPheno | Cryptorchidism | 1.33e-03 | 780 | 7 | 5 | HP:0000028 | |
| HumanPheno | Hypertrichosis | 1.36e-03 | 425 | 7 | 4 | HP:0000998 | |
| HumanPheno | Abnormal thyroid morphology | 1.43e-03 | 183 | 7 | 3 | HP:0011772 | |
| HumanPheno | Tetralogy of Fallot | 1.48e-03 | 185 | 7 | 3 | HP:0001636 | |
| HumanPheno | Broad philtrum | 1.56e-03 | 45 | 7 | 2 | HP:0000289 | |
| HumanPheno | Enlarged posterior fossa | 1.67e-03 | 193 | 7 | 3 | HP:0005445 | |
| HumanPheno | Aplasia/Hypoplasia of the vagina | 1.70e-03 | 47 | 7 | 2 | HP:0011026 | |
| HumanPheno | Rib fusion | 1.77e-03 | 48 | 7 | 2 | HP:0000902 | |
| HumanPheno | Hypoplastic fingernail | 2.16e-03 | 53 | 7 | 2 | HP:0001804 | |
| HumanPheno | Dislocated radial head | 2.24e-03 | 54 | 7 | 2 | HP:0003083 | |
| HumanPheno | Intracranial cystic lesion | 2.41e-03 | 219 | 7 | 3 | HP:0010576 | |
| HumanPheno | Abnormal hair quantity | 2.45e-03 | 888 | 7 | 5 | HP:0011362 | |
| HumanPheno | Abnormal posterior cranial fossa morphology | 2.48e-03 | 221 | 7 | 3 | HP:0000932 | |
| HumanPheno | Abnormality of the radial head | 2.49e-03 | 57 | 7 | 2 | HP:0003995 | |
| HumanPheno | Thyroid carcinoma | 2.49e-03 | 57 | 7 | 2 | HP:0002890 | |
| HumanPheno | Central nervous system cyst | 2.51e-03 | 222 | 7 | 3 | HP:0030724 | |
| HumanPheno | Primary adrenal insufficiency | 2.67e-03 | 59 | 7 | 2 | HP:0008207 | |
| HumanPheno | Abnormal 5th finger morphology | 2.70e-03 | 509 | 7 | 4 | HP:0004207 | |
| HumanPheno | Abnormality of the humeroradial joint | 2.94e-03 | 62 | 7 | 2 | HP:0100744 | |
| HumanPheno | Recurrent upper respiratory tract infections | 3.03e-03 | 237 | 7 | 3 | HP:0002788 | |
| HumanPheno | Congenital malformation of the great arteries | 3.11e-03 | 529 | 7 | 4 | HP:0011603 | |
| HumanPheno | Short 5th finger | 3.13e-03 | 64 | 7 | 2 | HP:0009237 | |
| HumanPheno | Flexion contracture of finger | 3.14e-03 | 240 | 7 | 3 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 3.14e-03 | 240 | 7 | 3 | HP:0010563 | |
| HumanPheno | Abnormality of dental eruption | 3.14e-03 | 240 | 7 | 3 | HP:0006292 | |
| HumanPheno | Camptodactyly of toe | 3.14e-03 | 240 | 7 | 3 | HP:0001836 | |
| HumanPheno | Joint contractures involving the joints of the feet | 3.14e-03 | 240 | 7 | 3 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 3.14e-03 | 240 | 7 | 3 | HP:0100490 | |
| HumanPheno | Flexion contracture of toe | 3.14e-03 | 240 | 7 | 3 | HP:0005830 | |
| HumanPheno | Interphalangeal joint contracture of finger | 3.14e-03 | 240 | 7 | 3 | HP:0001220 | |
| HumanPheno | Abnormality of the lower urinary tract | 3.15e-03 | 937 | 7 | 5 | HP:0010936 | |
| HumanPheno | Abnormal localization of kidney | 3.18e-03 | 241 | 7 | 3 | HP:0100542 | |
| HumanPheno | Toe joint contracture | 3.18e-03 | 241 | 7 | 3 | HP:0034675 | |
| HumanPheno | Abnormal skull base morphology | 3.21e-03 | 242 | 7 | 3 | HP:0002693 | |
| HumanPheno | Abnormality of circulating cortisol level | 3.33e-03 | 66 | 7 | 2 | HP:0011731 | |
| HumanPheno | Anonychia | 3.33e-03 | 66 | 7 | 2 | HP:0001798 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 3.33e-03 | 66 | 7 | 2 | HP:0006262 | |
| HumanPheno | Abnormal internal genitalia | 3.37e-03 | 1498 | 7 | 6 | HP:0000812 | |
| HumanPheno | Abnormal brain-evoked potentials | 3.37e-03 | 246 | 7 | 3 | HP:0430106 | |
| HumanPheno | Abnormality of circulating glucocorticoid level | 3.43e-03 | 67 | 7 | 2 | HP:0012111 | |
| HumanPheno | External genital hypoplasia | 3.46e-03 | 544 | 7 | 4 | HP:0003241 | |
| HumanPheno | Abnormal nasopharynx morphology | 3.49e-03 | 249 | 7 | 3 | HP:0001739 | |
| HumanPheno | Abnormality of the thyroid gland | 3.55e-03 | 548 | 7 | 4 | HP:0000820 | |
| MousePheno | decreased circulating glucagon level | 1.06e-04 | 20 | 11 | 2 | MP:0002696 | |
| MousePheno | abnormal mammary gland development | 1.12e-04 | 126 | 11 | 3 | MP:0000628 | |
| MousePheno | abnormal ear position | 2.10e-04 | 28 | 11 | 2 | MP:0000023 | |
| MousePheno | abnormal skin adnexa development | 3.06e-04 | 177 | 11 | 3 | MP:0020982 | |
| MousePheno | abnormal eye development | 3.80e-04 | 482 | 11 | 4 | MP:0001286 | |
| MousePheno | abnormal circulating glucagon level | 4.32e-04 | 40 | 11 | 2 | MP:0002695 | |
| MousePheno | abnormal mammary gland morphology | 4.44e-04 | 201 | 11 | 3 | MP:0000627 | |
| MousePheno | abnormal apocrine gland morphology | 4.44e-04 | 201 | 11 | 3 | MP:0013554 | |
| MousePheno | abnormal optic cup morphology | 4.76e-04 | 42 | 11 | 2 | MP:0004269 | |
| MousePheno | abnormal pluripotent precursor cell morphology | 4.76e-04 | 42 | 11 | 2 | MP:0002399 | |
| MousePheno | abnormal branching of the mammary ductal tree | 4.76e-04 | 42 | 11 | 2 | MP:0000662 | |
| MousePheno | decreased circulating hormone level | 6.31e-04 | 551 | 11 | 4 | MP:0014457 | |
| MousePheno | abnormal gland development | 6.83e-04 | 233 | 11 | 3 | MP:0020973 | |
| MousePheno | abnormal forebrain size | 7.03e-04 | 51 | 11 | 2 | MP:0012137 | |
| MousePheno | skin edema | 7.59e-04 | 53 | 11 | 2 | MP:0001786 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 1.00e-03 | 61 | 11 | 2 | MP:0004701 | |
| MousePheno | abnormal mammary gland duct morphology | 1.04e-03 | 62 | 11 | 2 | MP:0009503 | |
| MousePheno | decreased hormone level | 1.08e-03 | 635 | 11 | 4 | MP:0014455 | |
| MousePheno | abnormal hippocampus pyramidal cell layer | 1.36e-03 | 71 | 11 | 2 | MP:0008284 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 1.40e-03 | 72 | 11 | 2 | MP:0004700 | |
| MousePheno | abnormal mammary gland epithelium morphology | 1.47e-03 | 74 | 11 | 2 | MP:0009504 | |
| MousePheno | abnormal insulin-like growth factor I level | 1.51e-03 | 75 | 11 | 2 | MP:0008831 | |
| Domain | BAF250/Osa | 3.15e-07 | 2 | 11 | 2 | IPR021906 | |
| Domain | BAF250_C | 3.15e-07 | 2 | 11 | 2 | IPR033388 | |
| Domain | BAF250_C | 3.15e-07 | 2 | 11 | 2 | PF12031 | |
| Domain | BRIGHT | 3.30e-05 | 15 | 11 | 2 | SM00501 | |
| Domain | - | 3.30e-05 | 15 | 11 | 2 | 1.10.150.60 | |
| Domain | ARID | 3.30e-05 | 15 | 11 | 2 | PF01388 | |
| Domain | ARID_dom | 3.30e-05 | 15 | 11 | 2 | IPR001606 | |
| Domain | ARID | 3.30e-05 | 15 | 11 | 2 | PS51011 | |
| Domain | - | 7.21e-03 | 222 | 11 | 2 | 1.25.10.10 | |
| Domain | ARM-like | 1.05e-02 | 270 | 11 | 2 | IPR011989 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 2.40e-07 | 110 | 8 | 4 | M48043 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 5.35e-07 | 31 | 8 | 3 | M39522 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 6.47e-05 | 22 | 8 | 2 | MM1370 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.14e-04 | 29 | 8 | 2 | M48076 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.66e-04 | 35 | 8 | 2 | M47969 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.86e-04 | 37 | 8 | 2 | M27797 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 2.40e-04 | 42 | 8 | 2 | M48237 | |
| Pathway | PID_HNF3A_PATHWAY | 2.63e-04 | 44 | 8 | 2 | M285 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 8.28e-04 | 78 | 8 | 2 | M27234 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.23e-03 | 95 | 8 | 2 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 1.28e-03 | 97 | 8 | 2 | M48262 | |
| Pathway | WP_THERMOGENESIS | 1.58e-03 | 108 | 8 | 2 | M39746 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.53e-03 | 137 | 8 | 2 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.71e-03 | 142 | 8 | 2 | M48257 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.98e-03 | 149 | 8 | 2 | M27888 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 4.72e-03 | 1387 | 8 | 4 | M734 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.31e-03 | 1432 | 8 | 4 | M509 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 6.38e-03 | 220 | 8 | 2 | M27794 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 7.37e-03 | 237 | 8 | 2 | M27786 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 8.43e-03 | 254 | 8 | 2 | M27131 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 9.62e-03 | 272 | 8 | 2 | M29619 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.13e-02 | 296 | 8 | 2 | M27869 | |
| Pubmed | 1.97e-09 | 9 | 11 | 3 | 37805104 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.33e-09 | 220 | 11 | 5 | 35785414 | |
| Pubmed | 1.16e-08 | 268 | 11 | 5 | 33640491 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 9.09e-08 | 2 | 11 | 2 | 37611161 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 32791957 | ||
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 34386776 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 9.09e-08 | 2 | 11 | 2 | 29890703 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 23202128 | ||
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 33890484 | ||
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 24788099 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 9.09e-08 | 2 | 11 | 2 | 28967863 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 33052929 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 9.09e-08 | 2 | 11 | 2 | 24562383 | |
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 9.09e-08 | 2 | 11 | 2 | 27562491 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.31e-07 | 40 | 11 | 3 | 34585037 | |
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 33432679 | ||
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 21647563 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 2.73e-07 | 3 | 11 | 2 | 22426308 | |
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 24382590 | ||
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 2.73e-07 | 3 | 11 | 2 | 26716708 | |
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 34512623 | ||
| Pubmed | Gli3 is a negative regulator of Tas1r3-expressing taste cells. | 5.45e-07 | 4 | 11 | 2 | 29415007 | |
| Pubmed | 5.45e-07 | 4 | 11 | 2 | 28863077 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 5.45e-07 | 4 | 11 | 2 | 15170388 | |
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 5.45e-07 | 4 | 11 | 2 | 11988099 | |
| Pubmed | 9.09e-07 | 5 | 11 | 2 | 38489371 | ||
| Pubmed | Recent advances in understanding chromatin remodeling by Swi/Snf complexes. | 9.09e-07 | 5 | 11 | 2 | 12672490 | |
| Pubmed | 9.09e-07 | 5 | 11 | 2 | 12200431 | ||
| Pubmed | 1.36e-06 | 6 | 11 | 2 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 1.36e-06 | 6 | 11 | 2 | 25081545 | |
| Pubmed | 1.77e-06 | 78 | 11 | 3 | 28611094 | ||
| Pubmed | 1.91e-06 | 7 | 11 | 2 | 23540691 | ||
| Pubmed | 2.13e-06 | 83 | 11 | 3 | 28794006 | ||
| Pubmed | Polymorphisms in steroid hormone pathway genes and mammographic density. | 2.54e-06 | 8 | 11 | 2 | 12602902 | |
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 23556151 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 3.27e-06 | 9 | 11 | 2 | 20086098 | |
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 19176441 | ||
| Pubmed | 4.09e-06 | 10 | 11 | 2 | 15922553 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 4.09e-06 | 10 | 11 | 2 | 23129809 | |
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 4.09e-06 | 10 | 11 | 2 | 16751102 | |
| Pubmed | 4.09e-06 | 10 | 11 | 2 | 12665591 | ||
| Pubmed | 4.99e-06 | 11 | 11 | 2 | 18003620 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.23e-06 | 398 | 11 | 4 | 35016035 | |
| Pubmed | Arid1a regulates bladder urothelium formation and maintenance. | 5.99e-06 | 12 | 11 | 2 | 35283102 | |
| Pubmed | 5.99e-06 | 12 | 11 | 2 | 11734557 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 6.98e-06 | 123 | 11 | 3 | 26912792 | |
| Pubmed | 7.08e-06 | 13 | 11 | 2 | 21093585 | ||
| Pubmed | 7.08e-06 | 13 | 11 | 2 | 17340523 | ||
| Pubmed | Blood pressure and hypertension are associated with 7 loci in the Japanese population. | 7.08e-06 | 13 | 11 | 2 | 20479155 | |
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 9.53e-06 | 15 | 11 | 2 | 11175787 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 9.53e-06 | 15 | 11 | 2 | 17255939 | |
| Pubmed | 9.53e-06 | 15 | 11 | 2 | 23785148 | ||
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 9.53e-06 | 15 | 11 | 2 | 17920018 | |
| Pubmed | 9.53e-06 | 15 | 11 | 2 | 11263494 | ||
| Pubmed | 1.09e-05 | 16 | 11 | 2 | 21572416 | ||
| Pubmed | Overactivation of hedgehog signaling alters development of the ovarian vasculature in mice. | 1.23e-05 | 17 | 11 | 2 | 22402963 | |
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 1.23e-05 | 17 | 11 | 2 | 12368262 | |
| Pubmed | 1.23e-05 | 17 | 11 | 2 | 11078522 | ||
| Pubmed | 1.23e-05 | 17 | 11 | 2 | 19183483 | ||
| Pubmed | 1.23e-05 | 17 | 11 | 2 | 20381444 | ||
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 1.39e-05 | 18 | 11 | 2 | 23698369 | |
| Pubmed | SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression. | 1.39e-05 | 18 | 11 | 2 | 29996942 | |
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 1.55e-05 | 19 | 11 | 2 | 12110891 | |
| Pubmed | 1.55e-05 | 19 | 11 | 2 | 16932743 | ||
| Pubmed | Genome-wide association study of blood pressure and hypertension. | 1.55e-05 | 19 | 11 | 2 | 19430479 | |
| Pubmed | 1.72e-05 | 20 | 11 | 2 | 28154153 | ||
| Pubmed | 1.72e-05 | 20 | 11 | 2 | 14611647 | ||
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 1.90e-05 | 21 | 11 | 2 | 25249183 | |
| Pubmed | 2.29e-05 | 23 | 11 | 2 | 19737349 | ||
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 2.29e-05 | 23 | 11 | 2 | 8804307 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 2.29e-05 | 23 | 11 | 2 | 30962207 | |
| Pubmed | 2.50e-05 | 24 | 11 | 2 | 37543677 | ||
| Pubmed | 2.50e-05 | 24 | 11 | 2 | 32497091 | ||
| Pubmed | 2.50e-05 | 24 | 11 | 2 | 12215535 | ||
| Pubmed | 2.50e-05 | 24 | 11 | 2 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 2.50e-05 | 24 | 11 | 2 | 10078207 | |
| Pubmed | 2.94e-05 | 26 | 11 | 2 | 10778858 | ||
| Pubmed | 3.18e-05 | 27 | 11 | 2 | 29374058 | ||
| Pubmed | 3.34e-05 | 638 | 11 | 4 | 31182584 | ||
| Pubmed | 3.42e-05 | 28 | 11 | 2 | 30037996 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 3.42e-05 | 28 | 11 | 2 | 12192000 | |
| Pubmed | 3.68e-05 | 29 | 11 | 2 | 19279220 | ||
| Pubmed | 3.68e-05 | 29 | 11 | 2 | 36800290 | ||
| Pubmed | 3.94e-05 | 30 | 11 | 2 | 31043422 | ||
| Pubmed | 4.37e-05 | 1429 | 11 | 5 | 35140242 | ||
| Pubmed | 4.71e-05 | 233 | 11 | 3 | 37704626 | ||
| Pubmed | 5.04e-05 | 709 | 11 | 4 | 22988430 | ||
| Pubmed | 5.38e-05 | 35 | 11 | 2 | 32504627 | ||
| Pubmed | 6.02e-05 | 37 | 11 | 2 | 24335282 | ||
| Pubmed | Isolation and Characterization of Fetal Leydig Progenitor Cells of Male Mice. | 6.02e-05 | 37 | 11 | 2 | 26697723 | |
| Pubmed | 7.05e-05 | 40 | 11 | 2 | 28805822 | ||
| Pubmed | 8.38e-05 | 808 | 11 | 4 | 20412781 | ||
| Pubmed | 9.34e-05 | 46 | 11 | 2 | 20301533 | ||
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 1.10e-04 | 50 | 11 | 2 | 27716508 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.32e-04 | 908 | 11 | 4 | 19274049 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 1.33e-04 | 331 | 11 | 3 | 19490893 | |
| Pubmed | 1.34e-04 | 55 | 11 | 2 | 35945219 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.58e-04 | 351 | 11 | 3 | 38297188 | |
| Pubmed | 1.65e-04 | 61 | 11 | 2 | 20305087 | ||
| Interaction | SOX7 interactions | 8.22e-08 | 82 | 11 | 4 | int:SOX7 | |
| Interaction | NFIB interactions | 7.50e-07 | 142 | 11 | 4 | int:NFIB | |
| Interaction | GATA3 interactions | 2.25e-06 | 187 | 11 | 4 | int:GATA3 | |
| Interaction | NFIA interactions | 2.30e-06 | 188 | 11 | 4 | int:NFIA | |
| Interaction | NFIC interactions | 3.57e-06 | 210 | 11 | 4 | int:NFIC | |
| Interaction | AR interactions | 5.23e-06 | 992 | 11 | 6 | int:AR | |
| Interaction | GCM1 interactions | 5.95e-06 | 68 | 11 | 3 | int:GCM1 | |
| Interaction | ETV4 interactions | 6.21e-06 | 69 | 11 | 3 | int:ETV4 | |
| Interaction | ASF1A interactions | 7.01e-06 | 249 | 11 | 4 | int:ASF1A | |
| Interaction | CREBBP interactions | 9.08e-06 | 599 | 11 | 5 | int:CREBBP | |
| Interaction | IRF4 interactions | 1.17e-05 | 85 | 11 | 3 | int:IRF4 | |
| Interaction | FOXI1 interactions | 1.48e-05 | 92 | 11 | 3 | int:FOXI1 | |
| Interaction | SOX10 interactions | 1.48e-05 | 92 | 11 | 3 | int:SOX10 | |
| Interaction | SOX17 interactions | 1.63e-05 | 95 | 11 | 3 | int:SOX17 | |
| Interaction | SOX9 interactions | 1.73e-05 | 97 | 11 | 3 | int:SOX9 | |
| Interaction | PAX8 interactions | 2.60e-05 | 111 | 11 | 3 | int:PAX8 | |
| Interaction | TBR1 interactions | 2.74e-05 | 113 | 11 | 3 | int:TBR1 | |
| Interaction | SMARCC2 interactions | 2.77e-05 | 353 | 11 | 4 | int:SMARCC2 | |
| Interaction | TBXT interactions | 2.96e-05 | 116 | 11 | 3 | int:TBXT | |
| Interaction | ETS1 interactions | 3.36e-05 | 121 | 11 | 3 | int:ETS1 | |
| Interaction | TLE3 interactions | 3.55e-05 | 376 | 11 | 4 | int:TLE3 | |
| Interaction | PAX7 interactions | 3.62e-05 | 124 | 11 | 3 | int:PAX7 | |
| Interaction | SMAD2 interactions | 3.89e-05 | 385 | 11 | 4 | int:SMAD2 | |
| Interaction | PAX9 interactions | 4.17e-05 | 130 | 11 | 3 | int:PAX9 | |
| Interaction | TEX13B interactions | 5.12e-05 | 20 | 11 | 2 | int:TEX13B | |
| Interaction | SOX15 interactions | 5.31e-05 | 141 | 11 | 3 | int:SOX15 | |
| Interaction | SMAD3 interactions | 6.96e-05 | 447 | 11 | 4 | int:SMAD3 | |
| Interaction | KLF4 interactions | 7.73e-05 | 160 | 11 | 3 | int:KLF4 | |
| Interaction | EGR2 interactions | 9.42e-05 | 171 | 11 | 3 | int:EGR2 | |
| Interaction | TLX1 interactions | 1.01e-04 | 175 | 11 | 3 | int:TLX1 | |
| Interaction | ARID1B interactions | 1.04e-04 | 177 | 11 | 3 | int:ARID1B | |
| Interaction | ALG13 interactions | 1.15e-04 | 183 | 11 | 3 | int:ALG13 | |
| Interaction | HNF1B interactions | 1.29e-04 | 190 | 11 | 3 | int:HNF1B | |
| Interaction | MYOD1 interactions | 1.37e-04 | 194 | 11 | 3 | int:MYOD1 | |
| Interaction | KLF5 interactions | 1.39e-04 | 195 | 11 | 3 | int:KLF5 | |
| Interaction | GATA2 interactions | 1.48e-04 | 199 | 11 | 3 | int:GATA2 | |
| Interaction | FEV interactions | 1.57e-04 | 203 | 11 | 3 | int:FEV | |
| Interaction | E2F5 interactions | 1.69e-04 | 36 | 11 | 2 | int:E2F5 | |
| Interaction | ERG interactions | 2.07e-04 | 223 | 11 | 3 | int:ERG | |
| Interaction | NCOA3 interactions | 2.09e-04 | 224 | 11 | 3 | int:NCOA3 | |
| Interaction | NFIX interactions | 2.18e-04 | 227 | 11 | 3 | int:NFIX | |
| Interaction | TFF1 interactions | 2.20e-04 | 41 | 11 | 2 | int:TFF1 | |
| Interaction | NR5A2 interactions | 2.20e-04 | 41 | 11 | 2 | int:NR5A2 | |
| Interaction | RARB interactions | 2.77e-04 | 46 | 11 | 2 | int:RARB | |
| Interaction | CRX interactions | 3.03e-04 | 254 | 11 | 3 | int:CRX | |
| Interaction | HNF4A interactions | 3.82e-04 | 275 | 11 | 3 | int:HNF4A | |
| Interaction | TPRX2 interactions | 4.10e-04 | 56 | 11 | 2 | int:TPRX2 | |
| Interaction | SMARCE1 interactions | 4.33e-04 | 287 | 11 | 3 | int:SMARCE1 | |
| Interaction | RARG interactions | 4.40e-04 | 58 | 11 | 2 | int:RARG | |
| Interaction | TLX3 interactions | 4.51e-04 | 291 | 11 | 3 | int:TLX3 | |
| Interaction | FLI1 interactions | 5.03e-04 | 62 | 11 | 2 | int:FLI1 | |
| Interaction | SP7 interactions | 5.13e-04 | 304 | 11 | 3 | int:SP7 | |
| Interaction | SAP18 interactions | 5.18e-04 | 305 | 11 | 3 | int:SAP18 | |
| Interaction | FOS interactions | 5.53e-04 | 312 | 11 | 3 | int:FOS | |
| Interaction | BICRA interactions | 5.87e-04 | 67 | 11 | 2 | int:BICRA | |
| Interaction | SMG7 interactions | 5.90e-04 | 319 | 11 | 3 | int:SMG7 | |
| Interaction | DCTN6 interactions | 6.05e-04 | 68 | 11 | 2 | int:DCTN6 | |
| Interaction | HAPSTR1 interactions | 7.44e-04 | 829 | 11 | 4 | int:HAPSTR1 | |
| Interaction | SS18L2 interactions | 7.55e-04 | 76 | 11 | 2 | int:SS18L2 | |
| Interaction | PAX6 interactions | 8.80e-04 | 366 | 11 | 3 | int:PAX6 | |
| Interaction | IRF1 interactions | 9.00e-04 | 83 | 11 | 2 | int:IRF1 | |
| Interaction | STK11IP interactions | 9.00e-04 | 83 | 11 | 2 | int:STK11IP | |
| Interaction | PGR interactions | 9.21e-04 | 84 | 11 | 2 | int:PGR | |
| Interaction | PAX2 interactions | 9.43e-04 | 85 | 11 | 2 | int:PAX2 | |
| Interaction | GSC interactions | 9.88e-04 | 87 | 11 | 2 | int:GSC | |
| Interaction | SS18 interactions | 1.01e-03 | 88 | 11 | 2 | int:SS18 | |
| Interaction | SMARCC1 interactions | 1.01e-03 | 384 | 11 | 3 | int:SMARCC1 | |
| Interaction | MKRN2 interactions | 1.02e-03 | 385 | 11 | 3 | int:MKRN2 | |
| Interaction | MYH6 interactions | 1.15e-03 | 94 | 11 | 2 | int:MYH6 | |
| Interaction | DPF3 interactions | 1.18e-03 | 95 | 11 | 2 | int:DPF3 | |
| Interaction | DPF1 interactions | 1.18e-03 | 95 | 11 | 2 | int:DPF1 | |
| Interaction | BCL7B interactions | 1.18e-03 | 95 | 11 | 2 | int:BCL7B | |
| Interaction | GATA4 interactions | 1.23e-03 | 411 | 11 | 3 | int:GATA4 | |
| Interaction | SS18L1 interactions | 1.25e-03 | 98 | 11 | 2 | int:SS18L1 | |
| Interaction | SNIP1 interactions | 1.28e-03 | 417 | 11 | 3 | int:SNIP1 | |
| Interaction | NUP35 interactions | 1.35e-03 | 424 | 11 | 3 | int:NUP35 | |
| Interaction | NR3C1 interactions | 1.36e-03 | 974 | 11 | 4 | int:NR3C1 | |
| Interaction | LHX1 interactions | 1.38e-03 | 103 | 11 | 2 | int:LHX1 | |
| Interaction | SUFU interactions | 1.46e-03 | 106 | 11 | 2 | int:SUFU | |
| Interaction | SMARCD3 interactions | 1.49e-03 | 107 | 11 | 2 | int:SMARCD3 | |
| Interaction | INTS6 interactions | 1.57e-03 | 110 | 11 | 2 | int:INTS6 | |
| Interaction | TRIM33 interactions | 1.63e-03 | 453 | 11 | 3 | int:TRIM33 | |
| Interaction | BCL7C interactions | 1.72e-03 | 115 | 11 | 2 | int:BCL7C | |
| Interaction | SMARCA4 interactions | 1.72e-03 | 462 | 11 | 3 | int:SMARCA4 | |
| Interaction | BRD9 interactions | 1.78e-03 | 117 | 11 | 2 | int:BRD9 | |
| Interaction | DDIT3 interactions | 1.87e-03 | 120 | 11 | 2 | int:DDIT3 | |
| Interaction | EYA2 interactions | 1.90e-03 | 121 | 11 | 2 | int:EYA2 | |
| Interaction | MLLT1 interactions | 1.96e-03 | 123 | 11 | 2 | int:MLLT1 | |
| Interaction | BCL7A interactions | 1.96e-03 | 123 | 11 | 2 | int:BCL7A | |
| Interaction | RNF138 interactions | 2.02e-03 | 125 | 11 | 2 | int:RNF138 | |
| Interaction | YAP1 interactions | 2.10e-03 | 1095 | 11 | 4 | int:YAP1 | |
| Interaction | NOL8 interactions | 2.12e-03 | 128 | 11 | 2 | int:NOL8 | |
| Interaction | BUB1 interactions | 2.42e-03 | 137 | 11 | 2 | int:BUB1 | |
| Interaction | PHF10 interactions | 2.49e-03 | 139 | 11 | 2 | int:PHF10 | |
| Interaction | SMAD4 interactions | 2.55e-03 | 530 | 11 | 3 | int:SMAD4 | |
| Interaction | TP53BP1 interactions | 2.59e-03 | 533 | 11 | 3 | int:TP53BP1 | |
| Interaction | TLX2 interactions | 2.60e-03 | 142 | 11 | 2 | int:TLX2 | |
| Interaction | TRPS1 interactions | 2.64e-03 | 143 | 11 | 2 | int:TRPS1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 1.11e-02 | 681 | 11 | 2 | chr1p36 | |
| GeneFamily | AT-rich interaction domain containing | 2.31e-05 | 15 | 9 | 2 | 418 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN | 5.18e-05 | 26 | 11 | 2 | M7999 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN | 5.18e-05 | 26 | 11 | 2 | MM510 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | 8.52e-05 | 1239 | 11 | 5 | M1743 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | 9.83e-05 | 1277 | 11 | 5 | MM1032 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.12e-05 | 186 | 11 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.12e-05 | 186 | 11 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.27e-05 | 194 | 11 | 3 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor|TCGA-Testes / Sample_Type by Project: Shred V9 | 5.04e-04 | 138 | 11 | 2 | f7c40156c34d2d910bbda5ba07540ad0f6f22981 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.72e-04 | 147 | 11 | 2 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | TCGA-Breast|World / Sample_Type by Project: Shred V9 | 5.95e-04 | 150 | 11 | 2 | 08686ba1acac5c58667bf62e2af84c691d6bbdfb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.19e-04 | 153 | 11 | 2 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.19e-04 | 153 | 11 | 2 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.19e-04 | 153 | 11 | 2 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | 18-Airway-Epithelial-Goblet-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 6.19e-04 | 153 | 11 | 2 | 14a60220e169ce642771636de982a7b02e5b2608 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 6.35e-04 | 155 | 11 | 2 | 00eef9f93a753a1fe1ab5fd8dae026e7be556cde | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C|TCGA-Thymus / Sample_Type by Project: Shred V9 | 7.02e-04 | 163 | 11 | 2 | 2dac87d15051151ccf193760ddd8b82534c3f922 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.19e-04 | 165 | 11 | 2 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.28e-04 | 166 | 11 | 2 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.28e-04 | 166 | 11 | 2 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-club_cell-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.99e-04 | 174 | 11 | 2 | 103594eeb600eb5bc9cbf09a65b286b3a3a18cdc | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.99e-04 | 174 | 11 | 2 | 46838b4bb9b4d8ce5e1c608a700e7f393bc52658 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.18e-04 | 176 | 11 | 2 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-04 | 180 | 11 | 2 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 8.64e-04 | 181 | 11 | 2 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.74e-04 | 182 | 11 | 2 | 1932d77491d6d46278f01fd70eb469ef1b356619 | |
| ToppCell | cellseq2-Immune-Hematopoietic-Granulocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.83e-04 | 183 | 11 | 2 | cfbf8539104cef9ca830ad4f6bb278746f7078f7 | |
| ToppCell | cellseq2-Immune-Hematopoietic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.83e-04 | 183 | 11 | 2 | 324ec4374b552da7ce03809945b3a0798342d4ba | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.83e-04 | 183 | 11 | 2 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.03e-04 | 185 | 11 | 2 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-04 | 185 | 11 | 2 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.12e-04 | 186 | 11 | 2 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 186 | 11 | 2 | 6c06163d7315f1c71b15fe76f2e696bf3fa73b67 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.12e-04 | 186 | 11 | 2 | 37b93ebd64ebbd08193a746e5bc9b350c2570733 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 186 | 11 | 2 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 186 | 11 | 2 | 78e3b00eb347d1aa197671e31be9b0c6e4235760 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.22e-04 | 187 | 11 | 2 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.22e-04 | 187 | 11 | 2 | 796046ff066a9c3847faa9bf1f8beccd956c01f7 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.22e-04 | 187 | 11 | 2 | 380c3e0bc73b266718893a3b3ca207ce5fd31883 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-04 | 187 | 11 | 2 | 5b3c3c6421efd25c740ae121968b5520bbdc07b2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.22e-04 | 187 | 11 | 2 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-04 | 187 | 11 | 2 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-04 | 188 | 11 | 2 | 137ed9958044fab7a13648affb469585d1c48cf6 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-04 | 188 | 11 | 2 | 8ffb5394f7b00ea483a5fe4df894d22fda935e5c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 9.32e-04 | 188 | 11 | 2 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-04 | 188 | 11 | 2 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-04 | 190 | 11 | 2 | 434de72dde09644efbddcaa643a4a3eaf5f643bf | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.52e-04 | 190 | 11 | 2 | 01e7747547ea1f3049a11a1717565ba71dd52bdc | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-04 | 190 | 11 | 2 | e647f9a2dcf7f2dffef53c45bbe171416518fd59 | |
| ToppCell | droplet-Trachea-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.52e-04 | 190 | 11 | 2 | 0114cf48612d78c3ada4d8a05850501fef6892c5 | |
| ToppCell | droplet-Bladder-nan-24m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-04 | 190 | 11 | 2 | 725657faf90b8ef0a286a3fd64ed18ab600aa2df | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.52e-04 | 190 | 11 | 2 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.52e-04 | 190 | 11 | 2 | 576c45a30a4808b47433bc6c2c41396135556c40 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-04 | 191 | 11 | 2 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.72e-04 | 192 | 11 | 2 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.82e-04 | 193 | 11 | 2 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 9.82e-04 | 193 | 11 | 2 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | facs-Trachea-24m-Epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.82e-04 | 193 | 11 | 2 | ec49a83b24371579d4ad46aad91c25115aa226f9 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-04 | 193 | 11 | 2 | ee91a796d0f6d4cee7a93a525689e716fdceeda5 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-04 | 193 | 11 | 2 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.82e-04 | 193 | 11 | 2 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.92e-04 | 194 | 11 | 2 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-04 | 194 | 11 | 2 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-04 | 194 | 11 | 2 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.00e-03 | 195 | 11 | 2 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 195 | 11 | 2 | 18220efbd2d6ce6aa7501744fe430b6b46f2fc30 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 195 | 11 | 2 | d6e2a5a15bea16de5f7ff09318c67d46ea923203 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-03 | 195 | 11 | 2 | 0c49d22c348aec6d8a1a976e7c88d0a3b48a4244 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 1.01e-03 | 196 | 11 | 2 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-03 | 197 | 11 | 2 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-03 | 199 | 11 | 2 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | (08)_Brush+PNEC|World / shred by cell type by condition | 1.04e-03 | 199 | 11 | 2 | f2e33cb569c25fc2732722cac295647e9bd8738f | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-03 | 200 | 11 | 2 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-03 | 200 | 11 | 2 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.05e-03 | 200 | 11 | 2 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-03 | 200 | 11 | 2 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-03 | 200 | 11 | 2 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-03 | 200 | 11 | 2 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 9.27e-05 | 192 | 11 | 3 | 1829_UP | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 9.41e-05 | 193 | 11 | 3 | 5839_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 11 | 3 | 3406_DN | |
| Drug | STOCK1N-35874; Down 200; 14uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 11 | 3 | 6561_DN | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 11 | 3 | 2873_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 11 | 3 | 2874_UP | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.02e-04 | 198 | 11 | 3 | 2715_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.03e-04 | 199 | 11 | 3 | 2386_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 199 | 11 | 3 | 3845_DN | |
| Drug | profenofos | 1.32e-04 | 36 | 11 | 2 | ctd:C024273 | |
| Drug | Androstenedione | 2.08e-04 | 45 | 11 | 2 | ctd:D000735 | |
| Drug | tallow | 2.54e-04 | 270 | 11 | 3 | ctd:C013698 | |
| Drug | tris(chloroethyl)phosphate | 3.11e-04 | 55 | 11 | 2 | ctd:C031324 | |
| Drug | AC1O4QIW | 3.58e-04 | 59 | 11 | 2 | CID006398478 | |
| Drug | Androgens | 4.21e-04 | 64 | 11 | 2 | ctd:D000728 | |
| Drug | Bortezomib | 4.89e-04 | 838 | 11 | 4 | ctd:D000069286 | |
| Drug | 2,3,4,7,8-pentachlorodibenzofuran | 5.78e-04 | 75 | 11 | 2 | ctd:C038890 | |
| Drug | 3,3',4,5'-tetrahydroxystilbene | 6.73e-04 | 81 | 11 | 2 | ctd:C041525 | |
| Drug | tris(2-butoxyethyl) phosphate | 7.24e-04 | 84 | 11 | 2 | ctd:C013320 | |
| Drug | hydroxyflutamide | 1.09e-03 | 103 | 11 | 2 | CID000091649 | |
| Drug | Estrone | 1.28e-03 | 112 | 11 | 2 | ctd:D004970 | |
| Drug | NSC98537 | 1.30e-03 | 473 | 11 | 3 | CID000005410 | |
| Drug | fulvestrant | 1.39e-03 | 484 | 11 | 3 | ctd:C070081 | |
| Drug | 8-MOP | 1.42e-03 | 118 | 11 | 2 | CID000004114 | |
| Drug | 4,4'-hexafluorisopropylidene diphenol | 2.05e-03 | 142 | 11 | 2 | ctd:C583074 | |
| Drug | Asbestos, Crocidolite | 2.13e-03 | 1241 | 11 | 4 | ctd:D017638 | |
| Drug | Diclofenac | 2.22e-03 | 570 | 11 | 3 | ctd:D004008 | |
| Drug | Methyl-1 (S-methylphosphoryl-3) imidazolium | 2.31e-03 | 151 | 11 | 2 | CID000051213 | |
| Drug | Mercury | 2.38e-03 | 584 | 11 | 3 | ctd:D008628 | |
| Drug | diphenylamine-2-carboxylate | 2.72e-03 | 164 | 11 | 2 | CID000004386 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.95e-03 | 171 | 11 | 2 | 7535_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.02e-03 | 173 | 11 | 2 | 1016_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.05e-03 | 174 | 11 | 2 | 6493_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; PC3; HT_HG-U133A | 3.23e-03 | 179 | 11 | 2 | 4248_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.26e-03 | 180 | 11 | 2 | 4541_DN | |
| Drug | mono-(2-ethylhexyl)phthalate | 3.33e-03 | 658 | 11 | 3 | ctd:C016599 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 3.41e-03 | 184 | 11 | 2 | 4610_DN | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 3.41e-03 | 184 | 11 | 2 | 2946_UP | |
| Drug | 1ga8 | 3.41e-03 | 184 | 11 | 2 | CID000445801 | |
| Drug | 2,4,4'-trichlorobiphenyl | 3.41e-03 | 1411 | 11 | 4 | ctd:C081766 | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 3.44e-03 | 185 | 11 | 2 | 1114_DN | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 3.44e-03 | 185 | 11 | 2 | 6931_UP | |
| Disease | Breast adenocarcinoma | 4.08e-07 | 41 | 11 | 3 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.08e-07 | 41 | 11 | 3 | C0496956 | |
| Disease | Breast Carcinoma | 8.35e-07 | 538 | 11 | 5 | C0678222 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.26e-06 | 5 | 11 | 2 | C3281201 | |
| Disease | Prostatic Neoplasms | 1.62e-06 | 616 | 11 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.62e-06 | 616 | 11 | 5 | C0376358 | |
| Disease | neuroblastoma (is_implicated_in) | 5.68e-06 | 10 | 11 | 2 | DOID:769 (is_implicated_in) | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 8.32e-06 | 12 | 11 | 2 | DOID:4914 (is_marker_for) | |
| Disease | Coffin-Siris syndrome | 9.83e-06 | 13 | 11 | 2 | C0265338 | |
| Disease | breast cancer (is_implicated_in) | 2.06e-05 | 150 | 11 | 3 | DOID:1612 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | 2.43e-05 | 1074 | 11 | 5 | C0006142 | |
| Disease | unipolar depression, systolic blood pressure | 7.04e-05 | 34 | 11 | 2 | EFO_0003761, EFO_0006335 | |
| Disease | Neuroblastoma | 1.35e-04 | 47 | 11 | 2 | C0027819 | |
| Disease | Male sterility | 1.41e-04 | 48 | 11 | 2 | C0917731 | |
| Disease | Male infertility | 1.41e-04 | 48 | 11 | 2 | C0021364 | |
| Disease | Subfertility, Male | 1.41e-04 | 48 | 11 | 2 | C0848676 | |
| Disease | stomach cancer (is_implicated_in) | 3.18e-04 | 72 | 11 | 2 | DOID:10534 (is_implicated_in) | |
| Disease | mean arterial pressure, alcohol drinking | 5.89e-04 | 98 | 11 | 2 | EFO_0004329, EFO_0006340 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 6.01e-04 | 99 | 11 | 2 | EFO_0004611, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 6.38e-04 | 102 | 11 | 2 | EFO_0004329, EFO_0004611 | |
| Disease | mean arterial pressure | 7.17e-04 | 499 | 11 | 3 | EFO_0006340 | |
| Disease | Liver carcinoma | 7.51e-04 | 507 | 11 | 3 | C2239176 | |
| Disease | Adenocarcinoma | 8.23e-04 | 116 | 11 | 2 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 8.23e-04 | 116 | 11 | 2 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 8.23e-04 | 116 | 11 | 2 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 8.23e-04 | 116 | 11 | 2 | C0205642 | |
| Disease | Carcinoma, Cribriform | 8.23e-04 | 116 | 11 | 2 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 8.23e-04 | 116 | 11 | 2 | C0205641 | |
| Disease | Mammary Neoplasms, Human | 8.31e-04 | 525 | 11 | 3 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 8.31e-04 | 525 | 11 | 3 | C4704874 | |
| Disease | Mammary Neoplasms | 8.40e-04 | 527 | 11 | 3 | C1458155 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.18e-03 | 139 | 11 | 2 | DOID:3908 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 1.23e-03 | 142 | 11 | 2 | DOID:10534 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 1.50e-03 | 157 | 11 | 2 | DOID:9256 (is_marker_for) | |
| Disease | smoking status measurement, diastolic blood pressure | 1.54e-03 | 159 | 11 | 2 | EFO_0006336, EFO_0006527 | |
| Disease | apolipoprotein B measurement | 1.63e-03 | 663 | 11 | 3 | EFO_0004615 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.73e-03 | 169 | 11 | 2 | DOID:3908 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLMNKMSQGNPGLGS | 956 | Q86V15 | |
| GPGMGISANNQMHGQ | 941 | Q8NFD5 | |
| NQSPSGAMSNLGMGQ | 1381 | Q8NFD5 | |
| GGTMANNSAGMAASP | 951 | O14497 | |
| PNESAGSMVNGMQNQ | 1301 | P10071 | |
| SQGPAMMSGNQMSGL | 66 | Q9UKI9 | |
| SGMGAMGAQQAASMN | 111 | P55317 | |
| LMQAKMNSDNGNAGP | 266 | P05093 | |
| MNSNMGTGTFGPVGN | 136 | Q96AH0 | |
| SSVGGMSMSPNQGLQ | 396 | Q9Y6Q9 | |
| GADSPNSKNGNMPMS | 856 | Q8NHU6 | |
| NSKNGNMPMSGNTGE | 861 | Q8NHU6 | |
| SSNGQMNGMKPPLSG | 551 | Q68D10 |